Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Instil Bio Inc TIL

Healthcare Biotechnology
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:TIL)

Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire 11 days ago

Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody

GlobeNewswire January 14, 2025

Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire November 13, 2024

Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer

GlobeNewswire September 16, 2024

Instil Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire August 13, 2024

Instil Bio and ImmuneOnco Announce License and Collaboration Agreement for Development of IMM2510, a Potentially Best-in-Class PD-L1xVEGF Bispecific Antibody, and IMM27M, a Novel Next-Generation Anti-CTLA-4 Antibody

GlobeNewswire August 1, 2024

Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire May 10, 2024

Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire March 21, 2024

Instil Bio Announces Strategic Update

GlobeNewswire January 16, 2024
View More News ››

Opinion & Analysis (NDAQ:TIL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:TIL)

Instil Bio, Inc. (NASDAQ:TIL): Promising Pipeline and Collab

http://beyondspx.com/2024/08/02/instil-bio-inc-nasdaqtil-promising-pipeline-and-collaboration-agreements-but-significant-challenges-ahead...
MikeTester - August 3, 2024

halted this morning

Anybody else watching this one?  Halted after upticking last week.
mapleleaf - June 21, 2021

November 7th, 2018 Till Receives Initial Cash Payment of US

http://tillcap.com/wp-content/uploads/2018/11/TIL-2018.11.07-NR-18-10-TILL-Receives-Initial-Cash-Payment-from-IG-Coppers-Sale-of-the...
CarrFlournoy - November 7, 2018

What Is a Share Repurchase? With 5 million cash do it

What Is a Share Repurchase? -- The Motley Fool https://www.fool.com/knowledge-center/what-is-a-share-repurchase.aspx ...
CarrFlournoy - November 6, 2018

EMX Royalty Receives $65 Million Cash (news out today)

distribution to Til Capital pending news now  should get paid the same time
CarrFlournoy - October 30, 2018

TILL ANNOUNCES IG COPPER'S CLOSING OF THE MALMYZH SALE

he  initial cash distribution by IGC to Till’s wholly-owned subsidiary Resource Re Ltd. (“RRL”) is expected to be...
CarrFlournoy - October 11, 2018
View more Bullboard ››

Kootenay Silver Inc.

Kootenay Silver Inc.

Kootenay Silver Inc. is a Canada-based exploration company engaged in the discovery and development of mineral projects in ...
View More »